| Financial Year |
March 31 2023 |
| Monetary Funds |
1,102,220,472.52 |
| Held-for-trading Financial Assets |
878,260.40 |
| Notes Receivable |
-- |
| Accounts Receivable |
536,557,975.30 |
| Advances to Suppliers |
213,004,400.10 |
| Other Receivables |
115,483,511.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
473,147,659.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
155,346,819.67 |
| Total Current Assets |
2,968,519,800.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
33,905,265.40 |
| Investment Properties |
21,800,757.96 |
| Fixed Assetes |
2,140,417,846.53 |
| Under-construction Projects |
721,818,447.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
289,270,954.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,226,567.32 |
| Deferred Income Tax Assets |
12,579,378.06 |
| Other Non-Current Assets |
407,069,085.86 |
| Sub-Total of Non-Current Assets |
3,637,878,731.97 |
| Total Assets |
6,606,398,531.97 |
| Short-Term Loans |
273,716,204.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
371,848,047.60 |
| Accounts Payable |
675,289,350.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
130,530,224.68 |
| Taxes Payable |
6,601,915.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
56,478,107.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,076,765.53 |
| Other Current Liabilities |
13,317,239.03 |
| Sub-Total of Current Liabilities |
1,686,654,856.06 |
| Long-term Loans |
400,812,640.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
210,000.00 |
| Deferred Income Tax Liabilities |
52,315,245.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
464,338,196.99 |
| Total Liabilities |
2,150,993,053.05 |
| Paid-In Capital(Or Share Stock) |
202,680,000.00 |
| Capital Surplus |
435,155,679.31 |
| Surplus Reserve |
143,663,673.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,141,027,118.17 |
| Minority Stockholder's Interest |
503,812,332.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,951,593,146.88 |
| Owner's Equity（Stockholder's Equity） |
4,455,405,478.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,606,398,531.97 |
